Advertisement

New Agents to Combat Neovascular AMD
Posted: 05/23/2025 | By: Custom Content Team

A recent article in Retinal Physician reports on multiple trials of molecules targeting the larger anti-vascular endothelial growth factor (VEGF) family, which may translate into a future of durable and efficacious therapies for age-related macular degeneration (AMD).

Question 1 of 5

What percentage of AMD patients develop neovascular AMD (nAMD)?

Choose 1

CategoriesView All Quizzes

Retina


Refractive Conditions


Cataract


Cornea


Ocular Surface Disease


Glaucoma


Systemic Disease



Conference Coverage